BioWorld MedTech

Jan. 24, 2014

J.P. Morgan Healthcare Conference: Private ophthalmic companies make their pitches to receptive audience

SAN FRANCISCO — Although this annual conference has long been and continues to be dominated by publicly-owned healthcare companies, once again this year there was an impressive roster of attractive private companies. Read More

Medtronic gains approval for MRI to be used with pacing systems

Washington Roundup: FDA publishes draft to update 1998 animal materials guidance

Report from Asia: Trademark trouble follows J&J overseas to Chinese market

Deals roundup: Valeant tendered purchase of outstanding Solta shares

BioWorld Survey: Let Us Know What You Think!

Financings roundup: OrthoAccel Tech snags $5 million equity round

Agreements/contracts: KCI gets new designations from Novation for V.A.C.Ulta

Product briefs

People in Places

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

BioWorld

Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...

Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

BioWorld

Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...

Microbiota modulates the antidepressant effects of GLP-1 analogues

BioWorld Science

Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...